Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 July 2019 | Story Ruan Bruwer | Photo Allan McKenzie
Karla Pretorius
Karla Pretorius (left) receiving the trophy as the Player of the Tournament at the Netball World Cup.

Karla Pretorius downplayed all the praise and rather credited her team after she received the biggest accolade in world netball.

The former netball player of the University of the Free State was named Player of the Tournament after the conclusion of the Netball World Cup on Sunday 21 July 2019, making her officially the world’s best netballer.

“I feel very honoured and grateful to have been named the best player. You are only as good as those you surround yourself with. So, a massive thanks to the team who did so well,” she said about the Proteas who had their best showing at the tournament in 24 years. They finished fourth. 

“This good run was obviously what inspired me to play as well as I did, and I am grateful to have been given this very special award,” Pretorius said. 

‘Carried herself with huge distinction’

She represented and later captained the Kovsies between 2009 and 2015. During that time, she scooped one award after the other. In 2014 and 2015, she was the Varsity Player of the Year.

Pretorius was twice named as the Player of the Match during the World Cup, and her 20 intercepts were the joint third most.

She completed her master’s in Dietetics at the UFS last year (2018) and is now playing professional netball in Australia.

According to the organisers, the Player of the Tournament celebrates “the outstanding performance of one particular player who, more than anyone else, exemplified her country’s desire to put themselves back among the elite of world netball”. 
“The fact that South Africa reached the final four for the first time since 1995, is in no small way thanks to her impeccable reading of the game, timing, and composure. She has carried herself both on and off court with huge distinction, and has rightly claimed this honour,” they said.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept